Core Viewpoint - The medical device industry is currently in a challenging phase, with "endurance" being a key theme. Leading companies are proactively adjusting their strategies, including product structure changes and international expansion, as seen with Mindray Medical [1][3]. Group 1: Company Strategies - Mindray Medical is increasing the proportion of in vitro diagnostic (IVD) products in its overall revenue while decreasing the share of life information and support products and medical imaging products [1]. - The company aims to shift from traditional medical equipment sales to a more sustainable consumable-driven business model through IVD products [1]. - As of mid-2025, Mindray's overseas revenue share rose to 49.77%, up from 39.59% in mid-2022, indicating a strong push for international market penetration [3]. Group 2: Industry Challenges - The IVD sector is facing intense price competition and regulatory challenges domestically, making it a difficult environment for growth [3]. - The overall revenue for the A-share IVD sector declined by 14.5% year-on-year in the first three quarters of 2025, with net profit down 26.4%, marking three consecutive years of decline [8]. Group 3: Company Performance - Ji'an Medical, another key player, reported a net profit of 16.03 billion yuan in 2022, showcasing the potential of the IVD sector despite the current downturn [3]. - Ji'an Medical's overseas revenue accounted for 85.47% of total revenue by mid-2025, highlighting its successful international expansion compared to peers [8]. - Despite a 48.89% drop in total revenue to 1.069 billion yuan in the first three quarters of 2025, Ji'an Medical's net profit increased by 16.11% to 1.589 billion yuan, supported by over 1.1 billion yuan in investment income [7]. Group 4: Investment Strategies - Ji'an Medical is focusing on stable cash management and increasing investments in venture capital and private equity rather than pursuing aggressive mergers and acquisitions [7]. - The company has diversified its investment portfolio, including stakes in companies like Xiaomi and NIO, and plans to use up to 17 billion yuan for wealth management [10]. - Ji'an Medical's stock price has shown resilience, with a 9.17% increase in 2024 and a slight decline of 1.33% in 2025, outperforming industry peers [7]. Group 5: Future Outlook - Ji'an Medical's management believes that the current market valuation does not reflect the company's true value, prompting share buyback initiatives to stabilize stock prices [10]. - The company has received FDA pre-market notifications for new IVD products, which could enhance its competitive edge in the market [11]. - The overall recovery of the industry is crucial for Ji'an Medical's main business, but its dual strategy of combining medical devices with investment could provide a viable path forward during challenging times [11].

6日，上证指数以震荡上行在4000点上方调整，最终收盘站稳4000点上方，报4083.67点，上涨1.50%。 截至收盘，深证成指报14022.55点，涨幅1.40%；创业板指报3319.29点，涨幅0.75%。 回顾A股历史，沪指突破4000点的情形并不多见，此前仅出现在两轮行情中，分别是2007年5月与2015 年4月两轮牛市。A股本轮行情首次站上4000点是在2025年10月29日，此后又在3800点到4000点附近反 复震荡，在去年年末蓄力多日后持续上扬，终于在2026年的第一个交易日（5日）再度站上4000点。与 前两轮行情相比，本轮突破具有明显的结构性特征，且市场参与者中，机构投资者占比增加，硬科技、 高端制造、新能源等符合国家战略方向的赛道领涨市场。 对于后市走势，多家市场机构判断，春季躁动值得期待。 羊城晚报讯 记者莫谨榕报道：6日，上证指数成功站稳4000点整数关口，收盘报4083.67点，录得13连 阳，创下十年收盘新高。当日市场呈现普涨格局，全市场成交额突破2.83万亿元，超4100只个股上涨。 在积极宏观政策支撑、宏观经济回暖及增量资金入市等多重因素的支撑下，沪指自2025年"924行 ...

Core Insights - The Chinese private equity investment industry has reached a historic turning point after years of adjustment, with long-term investors beginning to reap rewards as short-term speculators exit the market [1] - In 2025, the total fundraising amount for the industry is expected to exceed 1.16 trillion yuan, a year-on-year increase of 8%, with over 3,500 new funds, marking an 18% increase [1] Group 1: Structural Changes and Investment Strategies - The role of state-owned capital (国资) has been further strengthened, with local guiding funds and state-owned capital accounting for over 50% of contributions, while the fundraising of foreign currency funds has decreased by 55% year-on-year [3] - State-owned limited partners (LPs) are integrating national strategies and regional economic development goals into their investment decisions, with a clear directive to allocate 70% of funds to early-stage technology companies [3] - The investment strategy of VC/PE has shifted from broad-based approaches to more targeted investments, with a noticeable decrease in the concentration of large funds exceeding 5 billion yuan [3] Group 2: Focus on Hard Technology - Hard technology is expected to be the primary focus for private equity investments in 2025 and the coming years, encompassing areas such as artificial intelligence, robotics, semiconductors, low-altitude economy, commercial aerospace, life sciences, and new energy [5] - The establishment of the Science and Technology Innovation Board, Growth Enterprise Market, Hong Kong Stock Exchange, and Beijing Stock Exchange has provided critical windows for capitalizing on hard technology investments [5] - Early-stage financing transactions (A-round and earlier) are projected to account for 62% of total transactions, with small investments under 10 million yuan exceeding 67% [5] Group 3: Exit Strategies and Market Recovery - The exit environment is showing signs of recovery, particularly in the IPO market, with A-share and Hong Kong markets accounting for 16% and 33% of global IPO numbers and fundraising amounts, respectively [7] - The number of IPO cases for invested companies in Hong Kong increased by 46.9% year-on-year, while the fundraising amount grew by 148.1% [7] - Mergers and acquisitions (M&A) have also seen significant growth, with a year-on-year increase of 84% in exit cases, totaling 352 cases in the first three quarters of 2025 [7] Group 4: Long-term Vision and Future Outlook - The theme "Visionaries Win" reflects the need for foresight in navigating the challenges and opportunities within the private equity investment landscape [9] - The upcoming 15th China Capital Annual Conference aims to gather key players in the industry to discuss emerging trends and strategies for success in fundraising and investment [9][10] - The investment landscape is expected to evolve towards greater specialization, internationalization, and sustainability, driven by ongoing policy optimization and the deep integration of technology and industry [13]

"3500"不仅是数量的跨越，更是"硬科技"驱动下企业创新能级的跃升。2025年以来，昆山企业共有36项 技术攻关项目获上级立项支持，其中国家级项目17项，承担重大科技任务的能力增强。龙头企业的技术 突破，牵引全市产业向价值链高端攀升。在此基础之上，昆山创新型企业梯队加速崛起：全年认定江苏 独角兽企业5家、潜在独角兽企业18家、瞪羚企业124家，数量均创历史新高；作为后备军的国家级科技 型中小企业备案数首次突破4000家，达4263家，构建起"雁阵齐飞"的格局。 本报讯(记者范昕怡)记者1月6日从昆山市科技局获悉，最新数据显示，昆山市有效高新技术企业总量突 破3500家，连续12年位居苏州各板块首位。在总量持续领跑的同时，昆山全年高新技术企业申报数、公 示认定数、净增数均位列苏州第一。 近年来，昆山深化"研发在上海、制造在昆山"协同机制，依托重大平台推进产学研融合。培育端，昆山 建立科技企业监测系统，实施"做当年、备来年、谋三年"全生命周期服务，对超200家重点企业"点对 点"辅导，推动高企认定率提升近10个百分点；在政策端，全年落实高企奖补资金超1亿元，惠及企业 2146家。 ...

Core Insights - The transition of the stock market into a new development era is a milestone in China's economic and financial development, expected to have significant positive impacts on various sectors [1][19]. Group 1: Stock Market Growth and Support for High-Tech Enterprises - The stock market is anticipated to continue its growth, contributing more to high-quality economic development, with a projected market value exceeding 135 trillion yuan by 2026 [19]. - The acceleration of high-tech enterprise listings will activate the dual engines of financing and growth in the stock market, enhancing the market structure and valuation system [20]. - The rise of high-tech sectors is expected to optimize the stock market structure, with a significant shift of market funds towards high-quality technology assets [20]. Group 2: Asset Allocation and Financial Structure Changes - There is a notable structural change in asset allocation, with a decline in real estate investment and an increase in equity assets, driven by a low-interest environment and policy guidance [22][23]. - The shift towards direct financing is expected to rise, with capital markets becoming a focal point for monetary policy adjustments, enhancing the precision of funding allocation for high-risk, high-growth enterprises [23]. Group 3: Policy Support and Regulatory Environment - The government has been actively promoting a supportive environment for the stock market, with multiple policy signals aimed at enhancing investor confidence and market stability [12][13]. - Regulatory reforms are being implemented to protect investor rights and ensure a fair market environment, which is crucial for the healthy development of the stock market [13][14]. Group 4: Internationalization of the Renminbi - The development of a mature capital market is essential for the internationalization of the Renminbi, with increasing demand for Renminbi assets expected as the capital market expands [24].

21世纪经济报道记者 杨坪 深圳报道 2026年新年伊始，新一轮IPO现场检查重磅来袭。 1月5日晚间，中证协公布了2026年第一批首发企业现场检查抽签名单，11家拟IPO企业"中签"。 这些企业均为2025年11月~12月受理的项目，其中科创板数量最多，合计有6家企业入选，分别为蓝箭航天、频准激光、高凯技 术、汉诺医疗、韬盛科技、锐石创芯；创业板紧随其后，洛轴股份、粤芯半导体、九安智能、猎奇智能4家企业入选，上证主板 仅中盐股份1家企业入选。 | 企业名称 | 受理日期 | 拟上市板 | 募集资金(亿元) | 保存机构 | | --- | --- | --- | --- | --- | | 洛阳轴承集团股份有限公司 | 2025/11/28 | 创业板 | 18.00 | 中信建投 | | 上海频准激光科技股份有限公司 | 2025/12/8 | 科创板 | 14.10 | 中信建投 | | 粤芯半导体技术股份有限公司 | 2025/12/19 | 创业板 | 75.00 | 广发证券 | | 深圳汉诺医疗科技股份有限公司 | 2025/12/23 | 科创板 | 10.62 | 中信证券 | | 广东九安 ...

日前，由世界青年科学家创业基金（以下简称"青科基金"）投资的企业——纳百川新能源股份有限公司（股票简称：纳百川）在深圳证券交易所创业板挂 牌上市，开启资本市场新征程。 纳百川新能源股份有限公司成立于2007年10月，拥有浙江温州、安徽马鞍山、安徽滁州三处生产基地，超20万平方米生产场地，年营收超10亿元，电池液 冷板市场份额位于行业领军行列，拥有核心专利203项。公司主要从事新能源汽车动力电池热管理、燃油汽车动力系统热管理及储能电池热管理相关产品 的研发、生产和销售。纳百川上市发行价22.63元/股，开盘价跃升至60元/股，盘中走势稳健，涨幅高达165.13%，以亮眼表现点燃资本市场热情。 来源 |温度新闻、青科会传播中心、科技金融时报（记者 叶扬） 编辑 | 王姝 校读 | 胡丽华 责编 | 江英华 监制 | 尤成勇 青科基金管理合伙人张泽介绍，青科基金已投资数十家硬科技项目，包括华盛雷达、科荣达、纵慧芯光、血霁生物、迅翼卫通、空天动力、雷骥电子、芯 生代、超快激光、云象网络等。"青科基金首批投资企业已经进入收获期，在2026年预计有3家青科基金投后企业IPO上市。"张泽透露。 | ... | | | | ...

每日金句 天时、地利、人和三者齐全永远是理想状态，99%的创业者在创业之初都极 为艰难。没有信心怎么办？创业者必须有决心，有强烈的愿望想要成功，想要 解决某个行业内的问题，想要为这个社会做点事情……梦想和"野心"是一个创 始人最核心的竞争力。 一个心怀梦想的人，会极其自律、昼度夜思、殚精竭 虑、不知疲倦，因为他不是想赢，而是必须赢。 吴世春 | 梅花创投创始合伙人 黑马加速导师 这里认真推荐你： 报名 「吴世春·西安出行活动」 1月22日-24日 ， 吴世春将亲自带队 100家企业家 ， 去陕西西安线下游学 ， 走进科技制造 产业，打开万亿赛道蓝海。 你 在 创业路上遇到的问题和想法 ， 都可以找吴老师聊聊 。 如果你是 优质的项目，吴老师也会果断投 你 。 希望所有支持吴老师的人 ， 一如既往的相信他、支持他，大家 一起 加油！ 活动详情如下 ↓↓↓ 吴世春导师亲自带队 | 2026.01.22-24 走进科技制造产业 升级数字文旅体验 探索产业生态协同 打开万亿赛道蓝海 車 I 安装花叉 新北料 新化 在 回你不留,对 11 17, 科技演费、Al+产生的创出者看过来! 你将收获 百位 硬核创业者同行 与 ...

Core Viewpoint - Over 60 companies in the A-share market have forecasted their 2025 performance, with more than 80% expecting positive results, driven by macroeconomic recovery and industrial upgrades [1][2]. Group 1: Company Performance Forecasts - Hunan-based company Hualing Steel expects a net profit of 2.6 billion to 3 billion yuan for 2025, representing a year-on-year growth of 27.97% to 47.66% [1]. - Zijin Mining anticipates a net profit of 51 billion to 52 billion yuan for 2025, reflecting a year-on-year increase of approximately 59% to 62%, primarily due to rising sales prices of gold, copper, and silver [1][2]. - Luxshare Precision forecasts a net profit of 16.52 billion to 17.19 billion yuan for 2025, with a growth rate of 23.59% to 28.59% [2]. - AVIC Heavy Machinery expects a net profit of 11.5 billion yuan for 2025, showing a year-on-year growth of 11.06% [2]. Group 2: Loss Forecasts - Moer Technology is projected to incur a loss of 116.8 million to 73 million yuan in 2025, while Muxi Co. anticipates a loss of 76.3 million to 52.7 million yuan [2]. - Both Moer Technology and Muxi Co. are newly listed on the Sci-Tech Innovation Board and are recognized as "domestic GPU first and second stocks," respectively, despite their current losses [2]. Group 3: Industry Trends - The performance of companies is concentrated in sectors such as materials and mining, new materials, electronic communications, and consumer services, indicating a trend towards hard technology enterprises benefiting from core technological barriers [1]. - The steel industry, represented by Hualing Steel, is undergoing a deep adjustment phase, focusing on "reduction development and stock optimization," with ongoing supply-demand contradictions [3].

Core Insights - The Chinese beauty industry is undergoing a structural "migration" towards capital markets, with over 30 companies from the entire supply chain seeking listings on global exchanges by 2025, indicating a shift from marketing-driven growth to a focus on "hard technology" and globalization [1][6] Industry Overview - By the end of 2025, five beauty companies have successfully gone public, with over 25 others at various stages of the listing process, showcasing a comprehensive coverage of the entire supply chain [1] - The capital market is reassessing the value distribution in the beauty industry, shifting focus from marketing to upstream technology [3][11] Company Listings - A significant number of companies are targeting the Hong Kong Stock Exchange (HKEX) for their listings, with over half of the firms choosing this market due to its international characteristics aligning with their global ambitions [6][8] - Companies like Pitanium Limited have opted for the Nasdaq, focusing on high-end retail in Hong Kong, indicating a strategic choice based on business alignment and risk management [8] Capitalization Trends - The trend of companies seeking dual listings (A+H shares) reflects a complex capital strategy aimed at optimizing shareholder structure and facilitating cross-border mergers and acquisitions [8][11] - The average R&D investment for companies planning to go public has increased from less than 2% three years ago to 3-5% currently, with leading firms exceeding 5% [9][11] Supply Chain Dynamics - The focus on self-sufficient supply chains has become a priority, with companies recognizing the importance of controlling core raw materials in light of geopolitical changes and supply chain disruptions [11] - The emergence of raw material companies as pioneers in this capital wave indicates a response to industry pain points, aiming to reduce reliance on imported high-end active ingredients [11] Brand Strategies - Companies are increasingly establishing brand barriers through differentiated positioning to attract capital, with notable examples including谷雨 aiming to become the "first domestic whitening stock" and植物医生 targeting the "first single-brand beauty stock" in A-shares [5][11] - The trend of digital transformation in distribution channels is evident, with companies like聚水潭 and凯诘电商 reflecting the urgent need for enhanced operational efficiency and integrated channel systems [11] Sustainability and ESG Factors - Sustainable development and ESG considerations are beginning to influence the capital value of beauty companies, with eco-friendly packaging and green materials becoming competitive advantages [11]